Round led by Founders Fund as 40,000 customers drive more than $80B in payment volume

NEW YORK, June 17, 2025 — Ramp, the leading financial operations platform, announced its Series E financing, bringing its valuation to $16 billion. For the fifth time, a Ramp funding round was led by Founders Fund – the company’s first and largest investor. Total size was capped at $200 million and included participation from Thrive Capital, D1 Capital Partners, General Catalyst, GIC, ICONIQ Growth, Khosla Ventures, Sands Capital, 8VC, Lux Capital, Stripes, 137 Ventures, Avenir Growth, and Definition Capital.

Fast Facts

• To date, Ramp has saved customers $10 billion and 27.5 million hours.
• Ramp currently powers over $80 billion in annualized purchase volume across card transactions and bill payments.*
• Ramp serves more than 40,000 companies, including CBRE, Shopify, Anduril, Notion, Cursor, Vercel, Barry’s, and MAGNA-TILES.
• Ramp’s product line includes corporate cards and expense management, bill payments, procurement, travel booking, and treasury. Half of Ramp customers use two or more products across its platform.
• With this round, Ramp has raised $1.4 billion in total equity financing.

What follows is a letter Eric Glyman, co-founder and CEO of Ramp, shared with customers here.

* Ramp does not include bank transfers or non-monetized payments when calculating Total Purchase Volume.

*****

LET THE ROBOTS CHASE RECEIPTS

Today, Ramp reached a new valuation: $16 billion.

My favorite companies’ missions are simple:

• Increase the GDP of the internet (Stripe)
• Make humanity a multiplanetary species (SpaceX)
• Be Earth’s most customer-obsessed company (Amazon)

Ours can fit on a post-it too:

• Save your company time and money (without you noticing)

We’re building the financial operations platform for your business. Corporate cards, spend management, bill pay, procurement, travel, treasury, accounting automations. Yes, it all might sound quite boring! And that’s precisely why we’re building it.

Let the robots chase receipts and close your books, so you can use your brain and build things.

That’s the way AI was meant to be. Not the other way around.

You don’t lose the day. You give it away, five minutes at a time.

Five minutes searching for the hotel. Five minutes booking it. Five minutes chasing a receipt. Five minutes uploading it. Five minutes for your manager to approve it. Five minutes for finance to check if it’s policy compliant. Five minutes reconciling the books.

One hotel booking. Three employees. Five interruptions. Suddenly it’s lunch. What have you done today?

Ramp is your net for catching hours and dollars. It’s ‘quiet efficiency.’

It’s why we called our company Ramp. A ramp is quite literally a simple machine; like the lever or pulley, it helps you do more work with less force. The less you have to think about it, the better we’re doing our job.

For example, just last month we launched Price Drop. Book a hotel and our AI will automatically rebook it if the price drops. Time and money saved. Best of all, you barely notice.

Today is Day 2,283

Let me tell you about what we built for you in the last three-hundred and sixty-five.

1. We didn’t set out to create a better expense report, we set out to eliminate it. We doubled the percent of employee expense reports fully completed and coded without humans needing to lift a finger.
2. We want every minute you do choose to spend on Ramp to go further. We decreased the time spent per administrative task – reviewing expenses, approving trips, paying bills, moving deposits to grow yield, etc. – by more than 50%.
3. We believe every support ticket is a signal that our product should be more intuitive. We launched 300+ features and made it easier to contact Ramp; still, customers contacted us 34% less often.

Put together, our customers are getting three times more work done per minute spent on Ramp than they did just two years ago. Everything is faster and more intuitive.

From startups to family owned companies to leading enterprises, 40,000 businesses across every sector are choosing Ramp to reclaim their time and money.

Here are a few:

1. Construction One reduced their AP team’s time spent on monthly close by 75%, saving them 360 hours in the last year.
2. Poshmark hit their free cash flow goals 5 months ahead of schedule by redirecting their team’s energy toward strategic projects, not administrative burden.
3. An industrial company (we can’t name) processed $47 million through Ramp cards, using our built-in controls to prevent 9% of spend that was out-of-policy and saving $4 million.

What connects all these companies is their obsession with efficiency. We’re proud to play a small role in helping them move faster, operate smarter, and stretch every dollar further.

There’s never been a better time to be a Ramp customer. And here’s our commitment to you: this is the worst our product will ever be.

It’s time to talk about AI

Every finance professional is being asked how they use AI. And yet, most businesses don’t have a single software engineer – let alone one dedicated to finance.

We believe every business, no matter the size, should benefit from world-class engineering and recent breakthroughs in reasoning. It’s why we spend over 50% of our payroll on research and development. It’s also why we have more IOI and IMO medalists (world champion programmers and mathematicians) on our team than most countries – 13 if you’re wondering.

In 2025 alone, we’ve shipped 270 features. All were quietly built with the help of AI. It works, you don’t notice it. And that’s the way we like it. Here are my favorite three:

• Card & Expense: Our AI auto-fills memos and categories as soon as a swipe clears, flags anything that looks out of policy, and automatically suggests memos for any transactions that still need human context.
• Procurement: Price and Seat Intelligence benchmarks every SaaS quote against anonymized market data; if you’re paying above the 80th percentile or holding unused seats, Ramp surfaces the delta and recommends a target price.
• Treasury: Our cash forecasting predicts your liquidity needs and sweeps idle funds into higher-yield instruments. When upcoming payroll or vendor runs tighten the buffer, we automatically pull the cash back, so you earn more without risking an overdraft.

Ramp isn’t ‘with the help of AI’, it’s ‘done for you and we don’t mention it’ AI. Michael, Cursor’s CEO, and Rama, Notion’s CFO, summed it up better than I can…

“People ask how we’re using AI in finance and I have a simple answer for them. We use Ramp.” – Rama Katkar, CFO Notion

“Most finance tools feel like they were built by people who’ve never worked at a high-velocity startup. Ramp’s engineering team is elite and ships fast. They actually understand what velocity means.” – Michael Truell, CEO Cursor

We still serve just 1.5% of the US market

That’s our motivation.

Right now, we’re saving thousands of companies billions of dollars and hours a year. We should be saving millions of companies trillions of dollars and hours a year.

I can assure you I’m not just writing this because it sounds good.

There’s a lot more to do and a lot more to build. We’re grateful for the opportunity to earn your business every day – and we’ll keep delivering more time and money back to you with each one.

Job’s not finished.

– Eric

About Ramp
Ramp is a financial operations platform designed to save companies time and money. Our all-in-one solution combines payments, corporate cards, vendor management, procurement, travel booking, and automated bookkeeping with built-in intelligence to maximize the impact of every dollar and hour spent. Over 40,000 customers, from family farms to space startups, have saved $10 billion and 27.5 million hours with Ramp. Founded in 2019, Ramp enables tens of billions in purchases annually. Learn more at www.ramp.com.

Media Contact
[email protected]

SOURCE Ramp

CoinFund Leads Seed Round for iGaming Platform From Former Facebook Games Executive Sean Ryan

NEW YORK, June 17, 2025 — ZOOT (getzoot.us), a sweepstakes gaming platform bringing video game sensibilities to iGaming entertainment, today announced it has raised $6 million in seed funding led by CoinFund, one of the world’s first cryptonative investment firms, with participation from Griffin Gaming Partners to expand the current US-focused business to a global-facing, stablecoin-driven one. The investment further grows the opportunities for instant, borderless payments in digital entertainment as stablecoin adoption surges past $239 billion in circulation, with payment giants like Visa and PayPal racing to integrate crypto rails for faster, cheaper transactions.

Co-founded by gaming industry veterans John Cahill (ex-Sega, Shockwave, Yahoo Games and Open Wager) and Sean Ryan, who led Facebook’s multi-billion dollar games business, ZOOT is building an iGaming platform that pioneers a new approach to iGaming that combines the engagement of video games with the efficiency of blockchain-based payments. Ryan brings decades of experience from leadership roles including CEO of digital music service Listen.com/Rhapsody and co-founder of social casino games company OpenWager (home of leading sweeps product Luckyland Slots), which was successfully acquired by VGW in 2017.

“Blockchain gaming with real currency integration represents one of the most compelling opportunities in digital entertainment today,” said Sean Ryan, CEO and Co-Founder of ZOOT. “We’re bringing video game design principles to iGaming to create experiences that are not only entertaining, but also transparent and instantly rewarding. With stablecoins eliminating traditional payment friction, we can serve players globally with zero fees and instant payouts.”

Building on its successful launch in the US-focused sweepstakes sector, ZOOT’s upcoming global platform addresses key friction points in traditional online gaming—namely payment processing delays and geographic restrictions. The platform’s flagship games, including its leading Beer Pong adaptation of the classic Plinko game, show how traditional chance-based mechanics can be reimagined through a video game lens with more interactivity and greater audio and graphical fidelity.

“We are now seeing explosive growth in stablecoin adoption, and real-money gaming is a trillion-dollar market waiting to be transformed by crypto rails,” said David Pakman, Managing Partner and Head of Venture Investments at CoinFund. “Sean is one of the most thoughtful and experienced entrepreneurs in gaming, and we believe he and his team will be one of the largest winners in this market as they create a much more mainstream experience for real-money gaming players around the world.”

CoinFund, founded in 2015, has established itself as a leading blockchain investment firm with a portfolio of over 105 companies. The funding will accelerate ZOOT’s platform development and help the team prepare for international expansion. While ZOOT currently operates in the U.S. market, the company sees its biggest growth opportunity in bringing stablecoin-powered gaming to markets across Southeast Asia, Latin America, and Africa. The company plans to launch additional game titles and enhance its blockchain integration capabilities in the coming months.

About ZOOT

ZOOT is an innovative gaming platform that provides engaging gameplay leveraging blockchain technology to enable real-money gaming powered by stablecoin technology. Co-founded by industry veterans Sean Ryan and John Cahill, the company is headquartered in New York with a technology team based in Europe.

For more information, visit getzoot.us.

About CoinFund

CoinFund is one of the world’s first cryptonative investment firms founded in 2015 with over 105 portfolio companies and 6 investment vehicles. The firm champions the leaders of the new internet through venture investments, liquid strategies, and active participation in blockchain networks.

For more information, visit coinfund.io.

SOURCE CoinFund

The round follows a wave of adoption across U.S. health systems, with Nabla’s AI assistant now embedded in more than 130 healthcare organizations, including major academic medical centers, safety-net hospitals, community health centers and physician groups nationwide. Now, Nabla is expanding beyond documentation into a more agentic model of clinical AI. This next phase enhances clinical documentation integrity (CDI), initiates EHR actions, and adapts across care settings to support diverse clinical roles. By unifying ambient listening, dictation, coding, and command capabilities into a single extensible agentic platform, Nabla is building toward its long-term vision: a proactive assistant that intuitively streamlines existing workflows.

“We’re going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties,” said Alex Lebrun, co-founder and CEO of Nabla. “Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery. We see a future where AI not only documents care, but actively drives efficiency by executing actions within complex clinical workflows and environments.”

Nabla’s assistant is now used by leading systems and providers, including CVS Health, Children’s Hospital Los Angeles, Carle Health, Denver Health, University of Iowa Health Care. Over the past year, adoption has surged across ambulatory, behavioral health, pediatric, and emergency settings, with early expansion into inpatient and nursing workflows underway. Nabla is helping clinicians cut documentation time by more than half: peer-reviewed studies from University of Iowa Health Care and real-world data from Denver Health confirm significant reductions in clinician burnout and a 15-point increase in patient satisfaction.

The company has multiplied its revenue by five over the past 6 months and now supports more than 85,000 clinicians and 20 million annual encounters. Designed to serve a broad range of care environments, Nabla’s assistant is available in 35 languages and is increasingly used in rural hospitals, FQHCs, and children’s hospitals, where clinician time is stretched and operational efficiency is mission-critical. The platform integrates with Epic, Cerner, athenahealth, NextGen, Greenway and other major EHRs and is built on a privacy-first model.

Nabla is also a member of the Coalition for Health AI, helping shape responsible AI governance in clinical care. At its core is a domain-specific large language model, refined over several years using clinically grounded data and a robust evaluation framework. This foundation enables advanced customization without compromising accuracy. Nabla now processes more than 30 billion tokens each month, a scale that supports continuous refinement and delivers measurable ROI for health systems.

With this new capital, Nabla will build a comprehensive Adaptive Agentic Platform, accelerating product development:

• Proactive Coding Agent: Improving existing real-time support for ICD-10, HCC, and MCC coding, with upcoming features to guide E/M coding and surface compliance nudges.
• Context-Aware Agent: Building on existing support for patient summaries and pre-charting, Nabla is expanding its use of historical data to introduce smarter documentation, initiate orders, and direct EHR commands through an intuitive interface.
• Custom Care Setting Agent: Deploying new capabilities tailored for nurses, with early expansion into inpatient environments and other frontline roles.

“Nabla stands out as a pioneer in clinical AI—not just for its bold vision, but for its enterprise-grade product and remarkable speed of execution,” said Alexander Joel-Carbonell, Partner at HV Capital. “What Alex, Delphine, and Martin have built is nothing short of extraordinary. I’ve rarely seen a technology scale this quickly, earn this level of trust, and deliver such exceptional accuracy. Today, more than 130 Tier 1 healthcare organizations rely on Nabla, a testament to the team’s ability to pair technological excellence with deep empathy for clinicians. It’s a privilege to support this exceptional team on their mission to transform healthcare.”

Nabla’s growth has been accompanied by a strong focus on clinician experience and enterprise readiness. The platform consistently outperforms alternatives in side-by-side pilots based on note quality, deployment speed, and overall clinician preference. Health system partners cite streamlined onboarding, high adoption rates, and strong alignment with clinical workflows. The company’s customer success model is built on responsiveness and rapid iteration, with health system partners citing hands-on support and real-time feedback loops as key drivers of adoption and sustained use.

“We’ve never seen a technology adopted like this across our organization. As an academic medical center, we serve a wide range of clinical needs. Nabla’s lightweight rollout made it easy for clinicians to start using it immediately,” said Dr. James Blum, Chief Health Information Officer and Associate Professor of Anesthesiology, University of Iowa Physicians. “It fits cleanly into Epic and supports how our clinicians deliver care. What stands out just as much as the speed of adoption is the partnership. Nabla listens, adapts, and builds with us. That kind of collaboration drives meaningful change, and we’re excited for what’s ahead.”

About Nabla
Nabla is on a mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows. Its assistant helps clinicians generate high-quality notes in seconds through ambient documentation, dictation, and real-time coding support. Nabla integrates with all major EHRs, supports more than 35 languages, and is used across over 130 health systems and provider groups.

The company is evolving into an adaptive agentic platform that supports a wider range of clinical workflows, care settings, and provider roles, empowering clinicians to dedicate more time to patient care.

Nabla was founded by Alex LeBrun (CEO), Delphine Groll (COO), and Martin Raison (CTO). Its leadership includes Dr. Ed Lee, Chief Medical Officer and former CIO of The Permanente Federation. Nabla’s advisors include Yann LeCun (Meta) and Tony Fadell (Build Collective). The company has raised $120 million from HV Capital, Highland Europe, Cathay Innovation, and others.

Learn more at www.nabla.com

Media Contact
[email protected]

SOURCE Nabla

Experienced biotech executive joins board to support RBL’s venture creation and growth strategy

HOUSTON, June 17, 2025 — RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, announced the appointment of James Watson to its board of directors. Watson, an operating partner at Andreessen Horowitz and a seasoned executive in the life sciences sector, brings to RBL LLC extensive experience in business strategy, corporate development and venture-backed company building, strengthening the organization’s mission to accelerate lifesaving therapies from lab to clinic.

“The appointment of James Watson to our board reflects a powerful endorsement of RBL’s model and potential,” said Paul Wotton, RBL’s managing partner. “James has occupied high-level positions across the full life cycle of biotech innovation, from company formation and financing to the construction of valuable partnerships in this field. His insights into market dynamics and his ability to drive successful outcomes for emerging ventures such as ours will be critical as we continue to grow.”

“James’ leadership spans both operational roles within biotech companies and strategic roles at one of the world’s top venture firms,” said Omid Veiseh, Rice professor of bioengineering and managing partner of RBL. “His ability to bridge science and business, along with his track record in corporate development, aligns perfectly with RBL’s mission to translate Rice University’s biomedical breakthroughs into high-impact startups.”

“RBL is approaching company creation in an innovative and differentiated way, with a positive impact that is starting to be seen across the broader Houston life sciences community,” Watson said. “RBL has distinguished itself through its efficient approach to company formation, identifying substantive technologies with clear clinical applications and establishing focused enterprises to advance them. I was also particularly drawn to the strategic positioning of the studio in Houston, where it operates at the intersection of world-class academic research, clinical scale and entrepreneurial rigor, all fundamental components of building a successful scientific venture.”

Watson is currently serving as operating partner on the Bio + Health team at Andreessen Horowitz, where he leads business and corporate development for the firm’s life sciences portfolio. Prior to joining Andreessen Horowitz, he held executive positions at numerous biotech companies, including Carmot Therapeutics, where as chief business officer, he was head of strategy, finance and corporate development. At Carmot, Watson led the raising of over $200 million for the company’s pipeline and discovery platform and built business development relationships that significantly contributed to Carmot’s $2.7 billion acquisition by Roche. Notably, he also served as chief business officer and president ICT at Sigilon Therapeutics, where he led a $485 million cell therapies partnership with Lilly. Earlier in his career, Watson served as CEO of merchant banking at Burrill & Company, a life sciences investment bank, and held leadership roles at Alvine Pharmaceuticals, Incyte, Chemdex, The Wilkerson Group and Eli Lilly. He earned an MBA from Indiana University and a bachelor’s degree in economics from the University of Portsmouth.

Watson will join existing board members Wotton, Veiseh, Rima Chakrabarti, John Jaggers, Devyn Smith and Paul Cherukuri, an accomplished group of leaders with deep expertise in biotech innovation, clinical translation and venture building who together provide strategic guidance to help drive RBL’s continued growth and success.

About RBL LLC:

RBL LLC is a pioneering biotech venture creation studio based in Houston that is dedicated to accelerating the development of breakthrough medical technologies and therapies through company formation. RBL provides entrepreneurs, researchers and innovators with infrastructure, financial support and strategic guidance as well as access to laboratory space and shared resources in the Texas Medical Center Helix Park. For more information, please visit https://www.rbl-llc.com/.

Media Contact:

Russo Partners
David Schull or Liz Phillips
(347) 956-7697
[email protected]
[email protected]

SOURCE RBL LLC

Ubyx is founded by 30-Year Payments Veteran to Build Global Stablecoin Acceptance Network

NEW YORK, June 17, 2025 — Ubyx, the stablecoin clearing system that enables regulated banks and fintechs to redeem stablecoins at face value, today announced its $10M seed round led by Galaxy Ventures with participation from Coinbase Ventures, Founders Fund, VanEck, Mirana Ventures, LayerZero, Paxos, Boku, Payoneer, and Monerium.

Ubyx is designed to deliver stablecoin ubiquity, meaning global acceptance of many stablecoins. Participating issuers include: Paxos, Ripple, Agora, Transfero, Monerium, GMO Trust, BiLira, Juno (a Bitso company), Brale, Minteo, Tokenised GBP, Avenia, Agant, AllUnity, and Eurodollar.

The stablecoin market structure today has barriers to mass adoption. The paradigm of on/off-ramping into/out of the crypto world is a bottleneck for users. Each stablecoin issuer has to build their own distribution network, at great cost. Corporates and banks cannot currently hold stablecoins on their balance sheets as cash equivalents.

Ubyx addresses these issues and expands the market by providing a clearing system for stablecoins, connecting multiple issuers with multiple receiving institutions, allowing redemption of stablecoins for fiat at par value into existing bank and fintech accounts.

By solving market fragmentation, standardising redemption to support cash-equivalent accounting treatment, and aligning economic incentives, Ubyx will usher in the stablecoin epoch, as described in the recently published whitepaper.

Ubyx Key Features:

• Global acceptance: Issuers access a mutual redemption network with a common rulebook.
• Cash equivalence and singleness of money: Stablecoins can be deposited at par value.
• Promotes regulated off-ramps: Redemption through regulated channels with AML, KYC, fraud, and sanctions screening.
• Extends trusted relationships: Banks and fintechs establish a foothold in digital assets.

“Stablecoins become ubiquitous when there is a shared acceptance network, just like cards. Traditional banks and fintechs should provide wallets to accept a wide range of regulated stablecoins on many public-permissionless blockchains.” said Mike Giampapa, General Partner of Galaxy Ventures.

Shan Aggarwal, Vice President of Corporate and Business Development at Coinbase Ventures said, “Just like the internet changed how we communicate, stablecoins on public networks will change how we pay. Ubyx is a critical piece of the stack that will help make stablecoin acceptance universal.”

Bridget Harris, Associate at Founders Fund said, “As regulation solidifies and stablecoins proliferate, a clearing system is needed to make all of these assets interoperable and fungible. We’re proud to be backing Ubyx as they build the infrastructure to make stablecoins accepted globally.”

Ubyx Founder and CEO, Tony McLaughlin said, “Ubyx represents the coming of age of stablecoins as the industry self-organises to deliver stablecoin ubiquity. Ubyx enables a pluralistic market structure with multiple issuers, multiple blockchains and multiple currencies in a global, interoperable network. The future of payments is stablecoin native.”

Ubyx facilitates widespread TradFi adoption of public blockchain infrastructure, and will support multiple chains including: Aptos, Arbitrum, Avalanche, Base, Canton, Concordium, Hedera, Polygon, Solana, Starknet, Stellar, Sui, XDC, XRP Ledger, and ZKsync.

Scaling partners will provide TradFi players with wallets, blockchain analytics and other technology enablers. Launch partners include: Axelar, BitGo, Chainalysis, Chavanette Advisors, Copper, Dfns, Digital Asset, Fireblocks, GK8 by Galaxy, IntellectEU, Kaleido, LayerZero, Silence Labs, Taurus, TRM Labs, Utila, Zodia Custody, and Zuehlke.

Live operation is planned for Q4 2025, with currency expansion and progressive decentralization of governance and technology to follow. The Ubyx Association is open to industry participants, regulators, and other stakeholders to form stablecoin strategies, connect with partners, and prepare for the stablecoin epoch.

About Ubyx
Ubyx was founded to facilitate stablecoin ubiquity, connecting multiple issuers with multiple receiving institutions in a common settlement environment that allows redemption of stablecoins at par value and supports the singleness of money.

For more information, please visit https://www.ubyx.xyz

For press enquiries, please contact [email protected]

SOURCE Ubyx Inc.

MIAMI, June 17, 2025 — Arkay Beverages, the global pioneer in alcohol-free spirits, is officially opening its latest investment round, seeking to raise $150 million USD at a $1.5 billion valuation. This funding will accelerate Arkay’s mission to dominate the booming zero-proof beverage market worldwide.

Founded in 2011 by visionary entrepreneur Reynald Vito Grattagliano, Arkay was the first company to develop and commercialize a true alcohol-free whisky alternative. Since then, the company has revolutionized the non-alcoholic space with a complete range of zero-proof spirits and ready-to-drink mocktails. Arkay sold over 10 million bottles in 2024 and is now present in more than 35 countries.

In a major potential development, one of Japan’s largest spirits companies is currently in advanced discussions to acquire a 10% equity stake in Arkay for $150 million, validating Arkay’s leadership in the global alcohol-free revolution. This partnership would provide significant strategic access to the Asian market and reinforce Arkay’s positioning at the top of the category.

Arkay is currently inviting accredited investors to participate in this growth opportunity through the purchase of Class B shares as part of a private placement. A detailed Private Placement Memorandum (PPM) is being finalized and will be made available shortly to qualified investors only.

“Arkay is not just a beverage brand — it’s a movement,” said Grattagliano. “We are redefining what it means to enjoy a drink. Our goal is to offer the world a healthier, safer, and smarter way to socialize without compromising on taste or style.”

The capital raised will fund:

• Global marketing and brand campaigns
• Expansion into key markets in North America, Europe, the Middle East, and Asia
• Launch of innovative new product lines, including functional and adaptogenic drinks
• Strategic partnerships with leading hospitality and retail groups
• Inventory scale-up to meet rapidly growing demand

The timing of this raise aligns with strong consumer trends. The non-alcoholic spirits category is expected to surpass $240 billion by 2035, fueled by rising health consciousness, younger generations turning away from alcohol, and global regulatory shifts.

Arkay’s unique patented formula, combined with its cost-efficient production model and first-mover advantage, positions it as the category leader in zero-proof innovation.

For Accredited Investors Only:
To request access to the PPM or express interest in purchasing Class B shares, please contact:
Reynald Vito Grattagliano
Founder & Chairman
[email protected]
www.arkaybeverages.com

SOURCE Arkay Beverages

Existing investors provide funding to finish international RESPONDER-HF trial 

TEWKSBURY, Mass., June 17, 2025 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the company’s existing investment syndicate of Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, and two strategic investors.

The funds will be used to complete the ongoing RESPONDER-HF trial, a double-blinded, randomized, sham-controlled, confirmatory trial of the Corvia^® Atrial Shunt currently underway at more than 65 institutions on three continents. The study is expected to generate the final supportive clinical data required for FDA approval of the shunt as a breakthrough treatment for heart failure with preserved and mildly reduced ejection fraction (HFpEF/HFmrEF).

“We are profoundly grateful for the unwavering support of our longstanding investors as we advance toward FDA submission of the Corvia Atrial Shunt,” said George Fazio, CEO of Corvia Medical. “Their commitment furthers our mission to bring this transformative heart failure treatment to millions of patients worldwide.”

Paul LaViolette, Board Chair of Corvia Medical, added, “We firmly believe Corvia has the potential to fundamentally alter the landscape of heart failure treatment, and our investors share that vision. With these resources, we are well-equipped to drive the company through the approval process and introduce this groundbreaking therapy to the market.”

About heart failure (HF) and the Corvia Atrial Shunt

More than 26 million people worldwide have HF, and the majority have HFpEF, making it the largest unmet clinical need in cardiovascular medicine. The Corvia Atrial Shunt is designed to reduce elevated left atrial pressure (LAP), the primary contributor to HF symptoms, by creating a passage between the left and right atria, reducing HF events and improving quality of life. The Corvia Atrial Shunt was granted Breakthrough Device designation by the FDA in 2019. For information regarding RESPONDER-HF study eligibility, please visit https://treatmyheartfailure.com.

About Corvia Medical, Inc.

Corvia Medical, Inc. is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Founded in 2009 and headquartered in Tewksbury, MA, privately-held Corvia is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. Visit https://corviamedical.com.

MEDIA CONTACT:
Lisa Ensz
+1 978-654-6120
[email protected]

SOURCE Corvia Medical, Inc.

TOKYO, June 16, 2025 — Following the successful launch of its inaugural program, JETRO and Coolwater Capital are proud to announce Cohort 2 of the Emerging Fund Manager Accelerator. This initiative aims to equip Japan’s next generation of venture capitalists with the tools and global perspective needed to build institutional-grade, globally competitive funds.

The first cohort saw 17 GPs selected from hundreds of applicants across Japan, collectively targeting over $500M in fundraising. Highlights included in-depth training from leading U.S. VCs, a 125-person Japan Innovation Summit in San Francisco, and in-person visits to Tier 1 VC firms—marking a breakthrough in cross-border knowledge sharing.

“We saw real traction—new fund launches, global LP engagement, and deep peer connections,” said Winter Mead, Founder & CEO of Coolwater Capital. “Cohort 2 is about scaling that impact and deepening the infrastructure for Japan’s VC future.”

JETRO echoed this sentiment:

“The results of Cohort 1 proved Japan’s potential on the global VC stage,” said Tatsuhiko Shiono, Director of JETRO Startup. “We’re thrilled to deepen our collaboration with Coolwater and help more fund managers go global.”

What’s New in Cohort 2:

• Enhanced 1:1 fundraising and brand coaching
• Expanded shared services (LP strategy, IR, positioning)
• More localized support with hybrid delivery
• New podcast and content community for alumni

Key Dates:

• Applications open: June 11, 2025
• Deadline to apply: July 16, 2025
• Program launch: September 9–11 in Tokyo, followed by weekly virtual modules
• Capstone: Coolwater Investor Summit, November 17–19 in New York

The 3-month accelerator includes 8 modules plus networking events, office hours, and meetups. All programming is in English, with support for both in-person and online participation.

Who Should Apply:

Emerging VC managers, ex-founders, corporate spinouts, tech executives, and institutional investors with bold, Japan-focused investment theses.

About Coolwater Capital
Founded in San Francisco, Coolwater has supported over 300 emerging funds globally, helping raise $5B+ and back more than 8,400 startups.

About JETRO
The Japan External Trade Organization (JETRO) is a government agency committed to promoting innovation and supporting global trade and investment.

SOURCE Coolwater Capital

DENVER, June 16, 2025 — Colorado Energy Office (CEO) has awarded Liberty Schools J-4 School District a total of $1.9M in funding as part of a State initiative to support geothermal HVAC projects across Colorado.

Funding from CEO was made available through three sources; The Geothermal Energy Grant Program (GEGP); The Geothermal Energy Tax Credit Offering (GETCO); and The Public Buildings Electrification Grant (PBEG). The district received funding from all three sources.

GEGP and GETCO funding is specifically designated for HVAC renovations that utilize geothermal technology. The awarded PBEG funds will support the cost of transitioning from fossil fuels to high-efficiency electric heat pumps that will serve as the building’s primary heat source.

Liberty School District selected Millig Design Build as their comprehensive turnkey service provider. Millig will be responsible for the complete project cycle; including initial design development, full-scale implementation of the geothermal HVAC systems, and ongoing post-construction support.

“Partnering with Millig Design Build from the onset of this project has been seamless and the best decision for our district” said Rhonda Puckett, Liberty’s Superintendent, “Millig was instrumental in securing nearly $2M in grant funding through the Colorado Energy Office. Millig guided Liberty School District through every step of the process, and we truly could not have done any of this without them. It’s clear that Millig understands the unique needs of our district and has truly invested in our school and our vision for a sustainable future.”

Liberty School’s facilities currently include several failing systems that require immediate attention. These include a completely failed gymnasium’s heating unit and an outdated hydronic system. Additionally, the absence of both a cooling system and a ventilation system raises concerns about the comfort, health, and safety standards within the building.

“Unfortunately, hydronic heating systems in these older school buildings were not designed for adequate cooling or ventilation, a challenge Liberty School District has faced for many years,” said Aaron Tilden, PE, Senior Project Developer, Millig Design Build. “We are proud to be selected as their turnkey service provider for this crucial initiative. It is time to bring this facility into the 21st century with a state-of-the-art ground-source HVAC system that will help provide a healthy, safe, and comfortable learning environment.”

The Millig team performed a thorough facility analysis and is moving forward with plans to install a new Ground-Coupled Variable Refrigerant Flow system which will provide energy-efficient heating and cooling, while Energy Recovery Ventilators will ensure optimal indoor air quality and a new Packaged Rooftop Unit for the gymnasium will address the previous heating unit failure.

The project will be completed in two phases, all construction is scheduled to be completed by Fall of 2025.

About Millig Design Build
Millig Design Build is an integrated engineering, design, and construction firm specializing in turnkey facility improvements that address energy efficiency, building health and safety, and core infrastructure needs. We serve clients nationwide from four strategic offices in Kansas; Colorado; Oregon; and Washington; For more information, visit milligdb.com

Media Contact Information:
Veronica Guerrero | [email protected]

SOURCE Millig Design Build